NeoPharm CO., LTD. (KOSDAQ: 092730)
23,400
+200 (0.86%)
Sep 11, 2024, 3:19 PM KST
NeoPharm CO., LTD. Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | 22,929 | 23,213 | 17,027 | 17,713 | 18,131 | 19,245 | Upgrade
|
Depreciation & Amortization | 2,338 | 1,673 | 1,616 | 1,500 | 1,494 | 1,209 | Upgrade
|
Loss (Gain) From Sale of Assets | 14.46 | 3.7 | 6.05 | 3.23 | 10.81 | 7.28 | Upgrade
|
Asset Writedown & Restructuring Costs | 1.58 | 13.47 | 6.23 | 11.07 | - | 250.66 | Upgrade
|
Loss (Gain) From Sale of Investments | 2.76 | 2.76 | - | -48.48 | - | - | Upgrade
|
Stock-Based Compensation | - | - | - | - | - | 107.04 | Upgrade
|
Provision & Write-off of Bad Debts | 147.92 | 95.42 | -0.11 | 55.48 | -9.69 | 23.72 | Upgrade
|
Other Operating Activities | 128.88 | 834.24 | 896.16 | 1,416 | 1,928 | 47.57 | Upgrade
|
Change in Accounts Receivable | -4,534 | -2,109 | 855.53 | 972.12 | 544.96 | -248.42 | Upgrade
|
Change in Inventory | -5,085 | -1,840 | -1,108 | -94.7 | -2,831 | 516.95 | Upgrade
|
Change in Accounts Payable | 3,347 | 2,732 | -643.79 | 152.91 | 1,020 | -301.51 | Upgrade
|
Change in Other Net Operating Assets | -1,612 | -1,355 | -494.97 | 0.34 | -3,214 | -1,634 | Upgrade
|
Operating Cash Flow | 17,678 | 23,263 | 18,161 | 21,681 | 17,074 | 19,224 | Upgrade
|
Operating Cash Flow Growth | -17.48% | 28.10% | -16.24% | 26.99% | -11.19% | 18.82% | Upgrade
|
Capital Expenditures | -21,088 | -19,852 | -454 | -320.11 | -285.62 | -5,902 | Upgrade
|
Sale of Property, Plant & Equipment | - | 0.91 | 0.15 | 0.85 | 0.02 | - | Upgrade
|
Sale (Purchase) of Intangibles | -530.37 | -975.96 | -352.43 | -158 | -444.74 | -1,292 | Upgrade
|
Investment in Securities | 8,487 | 4,487 | -8,000 | -16,002 | -4,000 | -46,000 | Upgrade
|
Other Investing Activities | -9.25 | 4.02 | 8.57 | -203.9 | 19.51 | 0 | Upgrade
|
Investing Cash Flow | -13,130 | -16,353 | -8,800 | -16,689 | -4,739 | -53,205 | Upgrade
|
Long-Term Debt Issued | - | - | - | - | - | 4,000 | Upgrade
|
Total Debt Issued | - | - | - | - | - | 4,000 | Upgrade
|
Short-Term Debt Repaid | - | - | - | -4,000 | -400 | - | Upgrade
|
Long-Term Debt Repaid | - | -534.03 | -494.56 | -373.42 | -320.2 | -324.81 | Upgrade
|
Total Debt Repaid | -564.49 | -534.03 | -494.56 | -4,373 | -720.2 | -324.81 | Upgrade
|
Net Debt Issued (Repaid) | -564.49 | -534.03 | -494.56 | -4,373 | -720.2 | 3,675 | Upgrade
|
Issuance of Common Stock | - | - | - | - | - | 31,971 | Upgrade
|
Dividends Paid | -5,865 | -5,474 | -5,474 | -5,083 | -5,865 | -4,598 | Upgrade
|
Other Financing Activities | -10.07 | 91.79 | 218.63 | -62.13 | 16.24 | -0.31 | Upgrade
|
Financing Cash Flow | -6,440 | -5,917 | -5,750 | -9,519 | -6,569 | 31,047 | Upgrade
|
Foreign Exchange Rate Adjustments | -61.47 | 4.78 | 223.43 | 387.01 | -91.54 | 27.71 | Upgrade
|
Net Cash Flow | -1,954 | 998.06 | 3,834 | -4,140 | 5,673 | -2,906 | Upgrade
|
Free Cash Flow | -3,410 | 3,411 | 17,707 | 21,361 | 16,788 | 13,322 | Upgrade
|
Free Cash Flow Growth | - | -80.74% | -17.11% | 27.24% | 26.02% | -6.44% | Upgrade
|
Free Cash Flow Margin | -3.16% | 3.51% | 20.82% | 24.29% | 20.57% | 16.00% | Upgrade
|
Free Cash Flow Per Share | -436.10 | 436.12 | 2264.08 | 2731.38 | 2126.36 | 1761.20 | Upgrade
|
Cash Interest Paid | 35.13 | 20.1 | 8.84 | 39.51 | 57.9 | 11.18 | Upgrade
|
Cash Income Tax Paid | 6,569 | 6,363 | 5,716 | 5,069 | 4,708 | 5,297 | Upgrade
|
Levered Free Cash Flow | -10,513 | -4,494 | 13,094 | 17,851 | 11,643 | 7,997 | Upgrade
|
Unlevered Free Cash Flow | -10,490 | -4,480 | 13,100 | 17,875 | 11,678 | 8,007 | Upgrade
|
Change in Net Working Capital | 6,767 | 1,143 | 1,109 | -2,833 | 2,774 | 357.47 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.